Related Experiment Video
Updated: Jun 22, 2026
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
[Dendritic cell-based immunotherapy for multiple myeloma -- review].
Xue-Jun Zhu1, Long He, Xue-Mei Sun
1Department of Hematology, Traditional Chinese Medicine Hospital of Jiangsu Province, Nanjing, Jiangsu Province, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|June 25, 2009
Summary
Multiple myeloma (MM) treatments are insufficient. Dendritic cell (DC) immunotherapy, using tumor antigen-pulsed DCs, shows promise as a complementary therapy for MM patients, with ongoing research into its future development.
Area of Science:
- Immunology
- Oncology
- Cellular Therapy
Context:
- Multiple myeloma (MM) incidence is rising, yet current treatments remain unsatisfactory.
- There is a critical need for novel complementary therapeutic strategies for MM.
- Dendritic cells (DCs) are potent antigen-presenting cells crucial for initiating and regulating immune responses.
Purpose:
- To review current knowledge on MM-associated antigens.
- To summarize clinical trials investigating DC-based immunotherapy for MM.
- To discuss the future prospects of DC immunotherapy in MM patient care.
Summary:
- This review examines various antigens linked to multiple myeloma.
- It synthesizes findings from clinical trials evaluating dendritic cell immunotherapy in MM patients.
- The potential future development of DC immunotherapy for MM is explored.
Impact:
- Highlights the therapeutic potential of dendritic cell immunotherapy for multiple myeloma.
- Provides a comprehensive overview of DC-based strategies in MM treatment.
- Informs future research directions for enhancing MM patient outcomes through immunotherapy.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...